DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Kaku K, Watada H, Iwamoto Y. et al
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: A combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study.
Cardiovasc Diabetol 2014;
13: 65
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.